Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-25 @ 2:06 AM
NCT ID: NCT06046560
Eligibility Criteria: Inclusion Criteria: 1. Aged 27 - 79 years at the time of agreeing to participate in the program 2. Presence of type 2 diabetes (treated with metformin unless intolerant, may also be treated with DPP4i, sulfonylurea, pioglitazone, and/or basal insulin) 3. HbA1c 6.5-8.9%; AND 4. At elevated cardiovascular and/or renal risk defined as any diagnosed ASCVD, estimated ASCVD risk \>10%, congestive heart failure, non-alcoholic fatty liver disease, estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73m2, albuminuria above 300mg/g; and those aged 60 years or older with at least two of: active tobacco use, dyslipidemia (LDL-c above 160 mg/dL or 4.1 mmol/L, non-HDL-C above 190 mg/dL or 4.9 mmol/L, triglycerides above 175 mg/dL,) hypertension (2 systolic blood pressure values above 130 mmHg and/or 2 diastolic blood pressure values above 90 mmHg within 12 months,) or BMI above 30 5. Has seen a primary care provider within the Mass General Brigham network within the last year Exclusion Criteria: 1. Type 1 diabetes 2. Currently or previously prescribed an SGLT2i or GLP1-RA 3. Taking any short-acting insulin 4. History of diabetic ketoacidosis 5. History of hypoglycemia requiring hospitalization 6. Frequent (more than two times in 1 week) episodes of symptomatic hypoglycemia with blood glucose \<70 mg/dL 7. eGFR below 15 ml/min/m2 8. Mental incapacity, unwillingness, or language barriers precluding adequate understanding or cooperation, OR 9. Life expectancy less than 1 year or utilizing palliative care
Healthy Volunteers: True
Sex: ALL
Minimum Age: 27 Years
Maximum Age: 79 Years
Study: NCT06046560
Study Brief:
Protocol Section: NCT06046560